{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:40:26Z","timestamp":1793724026552,"version":"4.6.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.juro.2015.05.101","type":"journal-article","created":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T12:11:42Z","timestamp":1434111102000},"page":"1449-1455","source":"Crossref","is-referenced-by-count":9,"title":["PTP4A3 Independently Predicts Metastasis and Survival in Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy"],"prefix":"10.1097","volume":"194","author":[{"given":"Hsin-Chih","family":"Yeh","sequence":"first","affiliation":[{"name":"Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan"},{"name":"Department of Urology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chia","family":"Li","sequence":"additional","affiliation":[{"name":"Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan"},{"name":"Department of Urology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Nung","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzyh-Chyuan","family":"Hour","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry, Kaohsiung Medical University, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi-Wen","family":"Yeh","sequence":"additional","affiliation":[{"name":"Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ming","family":"Li","sequence":"additional","affiliation":[{"name":"Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan"},{"name":"Department of Urology, Ministry of Health and Welfare Pingtung Hospital, Pingtung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peir-In","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Li","family":"Chang","sequence":"additional","affiliation":[{"name":"Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Department of Microbiology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Feng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, Chi Mei Medical Center, Tainan, Taiwan"},{"name":"Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan"},{"name":"National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jeng","family":"Wu","sequence":"additional","affiliation":[{"name":"Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Center for Stem Cell Research, Kaohsiung Medical University, Kaohsiung, Taiwan"},{"name":"Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2015.05.101_bib1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.eururo.2013.03.032","article-title":"European guidelines on upper tract urothelial carcinomas: 2013 update","volume":"63","author":"Roupr\u00eat","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2015.05.101_bib2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.eururo.2012.02.018","article-title":"Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery","volume":"62","author":"Rink","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2015.05.101_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.cell.2004.05.018","article-title":"Protein tyrosine phosphatases in the human genome","volume":"117","author":"Alonso","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.juro.2015.05.101_bib4","doi-asserted-by":"crossref","first-page":"11882","DOI":"10.1074\/jbc.M312905200","article-title":"Structural insights into molecular function of the metastasis-associated phosphatase PRL-3","volume":"279","author":"Kozlov","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.juro.2015.05.101_bib5","first-page":"2716","article-title":"PRL-3 and PRL-1 promote cell migration, invasion, and metastasis","volume":"63","author":"Zeng","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2015.05.101_bib6","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1065817","article-title":"A phosphatase associated with metastasis of colorectal cancer","volume":"294","author":"Saha","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.juro.2015.05.101_bib7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1245\/s10434-008-0214-6","article-title":"High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients","volume":"16","author":"Wang","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.juro.2015.05.101_bib8","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00432-010-0786-y","article-title":"Prognostic and metastatic value of phosphatase of regenerating liver-3 in invasive breast cancer","volume":"136","author":"Hao","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.juro.2015.05.101_bib9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/ijc.25082","article-title":"Phosphatase of regenerating liver-3 as a convergent therapeutic target for lymph node metastasis in esophageal squamous cell carcinoma","volume":"127","author":"Ooki","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.juro.2015.05.101_bib10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/00313020802579268","article-title":"PRL-3 facilitates angiogenesis and metastasis by increasing ERK phosphorylation and up-regulating the levels and activities of Rho-A\/C in lung cancer","volume":"41","author":"Ming","year":"2009","journal-title":"Pathology"},{"key":"10.1016\/j.juro.2015.05.101_bib11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12253-009-9200-y","article-title":"Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma","volume":"16","author":"Xu","year":"2010","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.juro.2015.05.101_bib12","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.1158\/1078-0432.CCR-14-1182","article-title":"AMACR amplification in myxofibrosarcomas: a mechanism of overexpression that promotes cell proliferation with\u00a0therapeutic relevance","volume":"20","author":"Li","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.juro.2015.05.101_bib13","first-page":"4244s","article-title":"Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors","volume":"46","author":"McCarty","year":"1986","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2015.05.101_bib14","doi-asserted-by":"crossref","first-page":"7318","DOI":"10.1158\/1078-0432.CCR-04-0485","article-title":"High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases","volume":"10","author":"Kato","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.juro.2015.05.101_bib15","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1158\/0008-5472.CAN-05-3116","article-title":"PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility","volume":"66","author":"Fiordalisi","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2015.05.101_bib16","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1158\/0008-5472.CAN-06-3598","article-title":"PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition","volume":"67","author":"Wang","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2015.05.101_bib17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bbamcr.2007.11.004","article-title":"Ezrin is a specific and direct target of protein tyrosine phosphatase PRL-3","volume":"1783","author":"Forte","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.juro.2015.05.101_bib18","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.4161\/cbt.8.14.8695","article-title":"PRL-3 promotes epithelial mesenchymal transition by regulating cadherin directly","volume":"8","author":"Liu","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.juro.2015.05.101_bib19","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1074\/jbc.M608940200","article-title":"PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation","volume":"282","author":"Liang","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.juro.2015.05.101_bib20","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1074\/jbc.M113.480038","article-title":"Protein-tyrosine phosphatase 4A3 (PTP4A3) promotes vascular endothelial growth factor signaling and enables endothelial cell motility","volume":"289","author":"Zimmerman","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.juro.2015.05.101_bib21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/sj.bjc.6603261","article-title":"Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer","volume":"95","author":"Radke","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.juro.2015.05.101_bib22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1476-4598-8-110","article-title":"PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1-ERK1\/2 and-MMP2 signaling","volume":"8","author":"Peng","year":"2009","journal-title":"Mol Cancer"},{"key":"10.1016\/j.juro.2015.05.101_bib23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1245\/s10434-012-2395-2","article-title":"Upregulation of protein tyrosine phosphatase type IVA member 3 (PTP4A3\/PRL-3) is associated with tumor differentiation and a poor prognosis in human hepatocellular carcinoma","volume":"20","author":"Mayinuer","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.juro.2015.05.101_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000292649","article-title":"Constitutive suppression of PRL-3 inhibits invasion and proliferation of gastric cancer cell in\u00a0vitro and in\u00a0vivo","volume":"77","author":"Matsukawa","year":"2010","journal-title":"Pathobiology"},{"key":"10.1016\/j.juro.2015.05.101_bib25","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1016\/j.bmcl.2013.04.092","article-title":"Rhodanine-based PRL-3 inhibitors blocked the migration and invasion of metastatic cancer cells","volume":"23","author":"Min","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.juro.2015.05.101_bib26","doi-asserted-by":"crossref","first-page":"7723","DOI":"10.1158\/0008-5472.CAN-09-4360","article-title":"Image-based chemical screening identifies drug efflux inhibitors in lung cancer cells","volume":"70","author":"Xia","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2015.05.101_bib27","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1158\/0008-5472.CAN-07-2349","article-title":"A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage","volume":"68","author":"Daouti","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2015.05.101_bib28","doi-asserted-by":"crossref","first-page":"750","DOI":"10.4161\/cbt.7.5.5764","article-title":"Monoclonal antibodies target intracellular PRL phosphatases to inhibit cancer metastases in mice","volume":"7","author":"Guo","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.juro.2015.05.101_bib29","doi-asserted-by":"crossref","first-page":"99ra85","DOI":"10.1126\/scitranslmed.3002296","article-title":"Targeting intracellular oncoproteins with antibody therapy or vaccination","volume":"3","author":"Guo","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.juro.2015.05.101_bib30","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.cell.2012.02.065","article-title":"The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis","volume":"149","author":"Chan","year":"2012","journal-title":"Cell"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534715041518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534715041518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2015.05.101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T03:59:08Z","timestamp":1651204748000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2015.05.101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.1016\/j.juro.2015.05.101"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2015.05.101","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}